跳至主要内容
临床试验/NCT00820274
NCT00820274终止2 期

Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers

University Hospital, Limoges6 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
10
试验地点
6
主要终点
Measure of the diameter of the ulcer

研究概览

简要总结

To evaluate tolerance and efficiency of cryopreserved amniotic membranes in local treatment of resistant vascular ulcers.

To evaluate complete cicatrisation, efficiency on pain, prevention of infection, improvement of quality of life.

To evaluate rate of amputations and recurrence at one year after complete cicatrisation

详细描述

Treatment of patients suffering from vascular ulcers or amputation's wound from at least 6 months after or without possibility for surgical treatment. A cryopreserved amniotic membrane, obtained after caesarean from consenting women without any disease, is applied on the ulcer after serological checking and changed once a week.

Main criterias:

Tolerance will be evaluated on clinical criterias. Efficiency will be evaluated by measuring reduction of ulcer's area (reduction of at least 50 % at 6 months).

Secondary criterias:

Reduction of pain will be evaluated by analogic visual scale and evaluation of analgesic consumption.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obtained informed consent
  • Leg or foot arterial or mixed ulcer older than at least 3 months

排除标准

  • No obtained informed consent
  • Possibility for surgical treatment (revascularisation)
  • Age less than 18
  • Pregnancy
  • Indication for major amputation (below /above the knee)
  • Venous ulcer
  • Ulcer with infection and / or necrosis
  • Mycotic ulcer

结局指标

主要结局

Measure of the diameter of the ulcer

时间窗: Every week

次要结局

未报告次要终点

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Evaluation of the Cryopreserved Amniotic Membranes... | 临床试验